NHC vs. VRTX
Compare and contrast key facts about National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NHC or VRTX.
Correlation
The correlation between NHC and VRTX is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NHC vs. VRTX - Performance Comparison
Loading data...
Key characteristics
NHC:
0.28
VRTX:
-0.04
NHC:
0.61
VRTX:
0.22
NHC:
1.07
VRTX:
1.03
NHC:
0.26
VRTX:
0.03
NHC:
0.46
VRTX:
0.08
NHC:
18.88%
VRTX:
9.15%
NHC:
30.51%
VRTX:
28.62%
NHC:
-94.71%
VRTX:
-91.77%
NHC:
-21.05%
VRTX:
-14.72%
Fundamentals
NHC:
$1.68B
VRTX:
$112.64B
NHC:
$6.91
VRTX:
-$3.82
NHC:
0.00
VRTX:
2.61
NHC:
1.22
VRTX:
10.15
NHC:
1.67
VRTX:
6.83
NHC:
$1.37B
VRTX:
$11.09B
NHC:
$518.54M
VRTX:
$9.54B
NHC:
$165.83M
VRTX:
-$228.00M
Returns By Period
In the year-to-date period, NHC achieves a -0.40% return, which is significantly lower than VRTX's 9.43% return. Over the past 10 years, NHC has underperformed VRTX with an annualized return of 8.62%, while VRTX has yielded a comparatively higher 13.42% annualized return.
NHC
-0.40%
15.52%
-13.09%
8.45%
18.58%
13.79%
8.62%
VRTX
9.43%
-9.90%
-5.64%
-1.02%
19.44%
9.14%
13.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NHC vs. VRTX — Risk-Adjusted Performance Rank
NHC
VRTX
NHC vs. VRTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
NHC vs. VRTX - Dividend Comparison
NHC's dividend yield for the trailing twelve months is around 2.29%, while VRTX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NHC National HealthCare Corporation | 2.29% | 2.25% | 2.53% | 3.80% | 3.11% | 3.13% | 2.38% | 2.52% | 3.10% | 2.31% | 3.14% | 2.13% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
NHC vs. VRTX - Drawdown Comparison
The maximum NHC drawdown since its inception was -94.71%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for NHC and VRTX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
NHC vs. VRTX - Volatility Comparison
The current volatility for National HealthCare Corporation (NHC) is 9.51%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 13.50%. This indicates that NHC experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
NHC vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between National HealthCare Corporation and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NHC vs. VRTX - Profitability Comparison
NHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, National HealthCare Corporation reported a gross profit of 145.57M and revenue of 373.70M. Therefore, the gross margin over that period was 39.0%.
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
NHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, National HealthCare Corporation reported an operating income of 30.77M and revenue of 373.70M, resulting in an operating margin of 8.2%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
NHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, National HealthCare Corporation reported a net income of 32.21M and revenue of 373.70M, resulting in a net margin of 8.6%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.